Early research (Phase 1)Study completedNCT00514007What this trial is testingStudy of Continuous OSI-906 DosingWho this might be right forAdvanced Solid Tumors Astellas Pharma Inc 95
Large-scale testing (Phase 3)Study completedNCT00035334What this trial is testingStudy of the Safety and Efficacy of NC-503 in Secondary (AA) AmyloidosisWho this might be right forSecondary (AA) AmyloidosisRheumatoid ArthritisNephrotic Syndrome+3 more Bellus Health Inc. - a GSK company 150
Not applicableStudy completedNCT03091465What this trial is testingValidation of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Prognostic Classification for Targeted Therapies (TKI/mTOR Inhibitors) in Second Line After First Line Treatment With PazopanibWho this might be right forMetastatic Renal Cell Carcinoma Spanish Oncology Genito-Urinary Group 530
Testing effectiveness (Phase 2)UnknownNCT04913337What this trial is testingStudy of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor MalignanciesWho this might be right forMesotheliomaGlioblastomaRenal Cell Carcinoma+12 more NGM Biopharmaceuticals, Inc 179
Testing effectiveness (Phase 2)Study completedNCT01108445What this trial is testingPhase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell CarcinomaWho this might be right forAdvanced Non-clear Cell Renal Cell Carcinoma Duke University 131
Not applicableWithdrawnNCT04889495What this trial is testingA Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various CancerWho this might be right forNon-small Cell Lung CancerMetastatic Colorectal CancerMetastatic Breast Cancer+5 more Pfizer
Testing effectiveness (Phase 2)Study completedNCT01688973What this trial is testingTivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by SurgeryWho this might be right forRecurrent Renal Cell CarcinomaStage III Renal Cell CancerStage IV Renal Cell Cancer+2 more National Cancer Institute (NCI) 55
Early research (Phase 1)UnknownNCT05420519What this trial is testingClinical Study of CD70-targeted CAR-T Therapy for Advanced/Advanced Renal CancerWho this might be right forMetastatic TumorRenal Cell CarcinomaAdvanced Cancer Chongqing Precision Biotech Co., Ltd 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT04940299What this trial is testingTocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial CarcinomaWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Bladder Carcinoma+39 more M.D. Anderson Cancer Center 35
Not applicableUnknownNCT05135832What this trial is testingPatient Reported Outcomes by Patients With Metastatic Renal Cell CarcinomaWho this might be right forMetastatic Renal Cell CarcinomaKidney CancerKidney Neoplasm+3 more Herlev and Gentofte Hospital 174
Large-scale testing (Phase 3)Active Not RecruitingNCT03937219What this trial is testingStudy of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Exelixis 855
Testing effectiveness (Phase 2)Ended earlyNCT00009919What this trial is testingSU5416 in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Previous TreatmentWho this might be right forRecurrent Renal Cell CancerStage IV Renal Cell Cancer National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Study completedNCT00066599What this trial is testingVoriconazole in Preventing Fungal Infections in Children With Neutropenia After ChemotherapyWho this might be right forKidney CancerLeukemiaLymphoma+6 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00630409What this trial is testingPhase II Clinical Trial of Gemcitabine and Doxil® for Metastatic Renal Cell CarcinomaWho this might be right forMetastatic Renal Cell Carcinoma University of Pittsburgh 5
Not applicableNot Yet RecruitingNCT07689812What this trial is testingRandomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.Who this might be right forNSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more Natera, Inc. 920
Testing effectiveness (Phase 2)Study completedNCT00003585What this trial is testingBiological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney CancerWho this might be right forKidney Cancer University of New Mexico 35
Early research (Phase 1)Ended earlyNCT02628535What this trial is testingSafety Study of MGD009 in B7-H3-expressing TumorsWho this might be right forMesotheliomaBladder CancerMelanoma+10 more MacroGenics 67
Very early researchNot Yet RecruitingNCT07671417What this trial is testingImaging Study in Metastatic Clear Cell RCC.Who this might be right forMetastatic Clear Cell Renal Cell Carcinoma RayzeBio, Inc. 10
Testing effectiveness (Phase 2)Study completedNCT01517243What this trial is testingPhase II Study of Alternating Sunitinib and TemsirolimusWho this might be right forMetastatic Renal Cell Carcinoma Dartmouth-Hitchcock Medical Center 37
Testing effectiveness (Phase 2)Study completedNCT00006026What this trial is testingNitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary TractWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer European Organisation for Research and Treatment of Cancer - EORTC 21